Cutaneous Adverse Effects in Patients Treated with BTK Inhibitors.

Simple Summary: Patients treated with BTK inhibitors frequently demonstrate dermatologic toxicities, such as bruising, rash, infections, mucosal symptoms, neutrophilic dermatoses, vasculitis, infections, nail plate abnormalities and hair changes. In most cases, skin toxicities remain mild. Proactive...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 18; no. 3; pp. 371 - 389
Autores principales: Robak, Ewa, Robak, Tadeusz
Formato: pictorial review Journal Article
Publicado: MDPI Feb2026
Acceso en línea:Ver este registro en EBSCOhost